S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.17%) $0.928
USD/NOK
(0.21%) $10.86
USD/GBP
(0.01%) $0.792
USD/RUB
(0.05%) $92.63

Realtime updates for Kiromic BioPharma, Inc. [KRBP]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 15:40

2.89% $ 2.85

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 15:40):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors...

Stats
Today's Volume 5 627.00
Average Volume 9 681.00
Market Cap 3.67M
EPS $-3.52 ( 2023-11-14 )
Next earnings date ( $0 ) 2024-05-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.230
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2024-03-18 Catlin Michael Buy 18 000 Restricted Stock Award
2024-03-18 Misajon Pamela Buy 18 000 Restricted Stock Award
2024-03-18 Nagel Michael Buy 18 000 Restricted Stock Award
2023-10-05 Bersani Pietro Buy 65 600 Restricted Stock Units
2023-10-05 Misajon Pamela Buy 7 500 Restricted Stock Units
INSIDER POWER
100.00
Last 47 transactions
Buy: 2 001 102 | Sell: 1 131 551

Kiromic BioPharma, Inc. Correlation

10 Most Positive Correlations
GOODM0.896
RMRM0.885
ASPU0.88
LSXMK0.876
LSXMA0.875
SIGA0.875
TRVN0.871
OPHC0.87
SATL0.869
BIOC0.868
10 Most Negative Correlations
FRSG-0.855
ITQ-0.853
TCVA-0.851
CPAQ-0.85
NVSA-0.848
TBSAU-0.846
BOCN-0.843
BTAQ-0.842
ASRT-0.841
AGGR-0.841

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kiromic BioPharma, Inc. Financials

Annual 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-19.09
Q4 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-534.72
Q3 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-3.52
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-6.42

Financial Reports:

No articles found.

Kiromic BioPharma, Inc.

Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement with Leon Office (H.K.) Ltd. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators